Details of the Drug

General Information of Drug (ID: DMAPDH2)

Drug Name

Cipaglucosidase alfa

Synonyms

Pombiliti

Indication

Disease Entry	ICD 11	Status	REF
Glycogen storage disease type II	5C51.3	Approved in EU	[1]
Pompe disease	5C51.3	Approved	[2]
------------------------------------------------------------------------------------

ATC Code

A16AB23: Cipaglucosidase alfa

A16AB: Enzymes

A16A: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS

A16: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS

A: ALIMENTARY TRACT AND METABOLISM

Drug Type

Enzyme replacement

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Alpha-glucosidase (GLA)	TTHCF4J	LYAG_HUMAN ; GANAB_HUMAN ; GANC_HUMAN	Replacement	[3]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Cipaglucosidase Alfa: First Approval. Drugs. 2023 Jun;83(8):739-745.
2	FDA Approved Drug Products from FDA Official Website. 2023. Application Number: 761204
3	Cipaglucosidase Alfa: First Approval. Drugs. 2023 Jun;83(8):739-745.